| Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) MJ Davies, DA D’Alessio, J Fradkin, WN Kernan, C Mathieu, G Mingrone, ... Diabetes care 41 (12), 2669, 2018 | 4388 | 2018 |
| Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes JB Green, MA Bethel, PW Armstrong, JB Buse, SS Engel, J Garg, R Josse, ... New England Journal of Medicine 373 (3), 232-242, 2015 | 3263 | 2015 |
| 5. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes—2022 American Diabetes Association Professional Practice Committee, ... Diabetes care 45 (Supplement_1), S60-S82, 2022 | 1639* | 2022 |
| Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ... The Lancet 392 (10157), 1519-1529, 2018 | 1503 | 2018 |
| Empagliflozin in patients with chronic kidney disease EMPA-Kidney Collaborative Group New England Journal of Medicine 388 (2), 117-127, 2023 | 1364 | 2023 |
| 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021 American Diabetes Association Diabetes care 44 (Supplement_1), S111-S124, 2021 | 1198 | 2021 |
| Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) MJ Davies, VR Aroda, BS Collins, RA Gabbay, J Green, NM Maruthur, ... Diabetes care 45 (11), 2753-2786, 2022 | 1024 | 2022 |
| 13. Children and Adolescents: Standards of Medical Care in Diabetes−2020 American Diabetes Association Diabetes Care 43 (Supplement_1), S163-S182, 2020 | 917* | 2020 |
| Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial C Gabay, P Emery, R Van Vollenhoven, A Dikranian, R Alten, K Pavelka, ... The Lancet 381 (9877), 1541-1550, 2013 | 848 | 2013 |
| Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) MJ Davies, VR Aroda, BS Collins, RA Gabbay, J Green, NM Maruthur, ... Diabetologia 65 (12), 1925-1966, 2022 | 664 | 2022 |
| 14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2020 American Diabetes Association Diabetes care 43 (Supplement_1), S183-S192, 2020 | 581 | 2020 |
| 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022 American Diabetes Association Professional Practice Committee, ... Diabetes care 45 (Supplement_1), S144-S174, 2022 | 460 | 2022 |
| Cardiovascular outcomes trials in type 2 diabetes: where do we go from here? Reflections from a diabetes care editors’ expert forum WT Cefalu, S Kaul, HC Gerstein, RR Holman, B Zinman, JS Skyler, ... Diabetes care 41 (1), 14-31, 2018 | 435 | 2018 |
| Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials C Baigent, JR Emberson, R Haynes, WG Herrington, P Judge, ... The Lancet 400 (10365), 1788-1801, 2022 | 359 | 2022 |
| Harmony Outcomes committees and investigators. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double … AF Hernandez, JB Green, S Janmohamed, RB D’Agostino Sr, CB Granger, ... Lancet 392 (10157), 1519-1529, 2018 | 351 | 2018 |
| Atrial Fibrillation and Diabetes Mellitus: JACC Review Topic of the Week A Wang, JB Green, JL Halperin, JP Piccini Journal of the American College of Cardiology 74 (8), 1107-1115, 2019 | 329 | 2019 |
| 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022 B Draznin, VR Aroda, G Bakris, G Benson, FM Brown, R Freeman, ... Diabetes care 45 (Suppl 1), S17-S38, 2022 | 273 | 2022 |
| Heart Failure With Preserved Ejection Fraction and Diabetes: JACC State-of-the-Art Review K McHugh, AD DeVore, J Wu, RA Matsouaka, GC Fonarow, ... Journal of the American College of Cardiology 73 (5), 602-611, 2019 | 268 | 2019 |
| The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study WG Herrington, D Preiss, R Haynes, M von Eynatten, N Staplin, ... Clinical kidney journal 11 (6), 749-761, 2018 | 261 | 2018 |
| 7. Diabetes Technology: Standards of Medical Care in Diabetes—2022 American Diabetes Association Professional Practice Committee, ... Diabetes Care 45 (Supplement_1), S97-S112, 2022 | 252* | 2022 |
